**Stop thinking of cancer as a "battle" you either win or lose.** I’m serious.
After watching how GitLab co-founder Sid Sijbrandij responded to his second bout with osteosarcoma, I realized our entire cultural metaphor for terminal illness is broken—and it’s costing us the very innovation we need to survive.
**I used to believe that if I got a "scary" diagnosis, I’d retreat to a beach, hug my family, and wait for the end.** Most of us would.
We’ve been conditioned to think that sickness requires a total shutdown of our professional selves.
But Sid just spent the last 18 months proving that for a certain breed of human, **founding a company isn’t a distraction from cancer; it’s the cure for the helplessness that comes with it.**
The news hit Hacker News like a lightning bolt this week, but the story has been brewing since he stepped down as CEO in late 2024.
While the rest of the world expected him to fade into a quiet retirement of "health management," **Sid was quietly applying the GitLab handbook to the most inefficient codebase in existence: the human genome.** It’s not about "bravery" in the way the nightly news describes it.
It’s about a systems architect refusing to accept a buggy OS.
When Sid Sijbrandij announced he was stepping down from the helm of GitLab, the $7 billion DevOps giant he built on the principle of radical transparency, the tech world offered its collective "thoughts and prayers." **We assumed his "fight" would happen in a sterile hospital room, disconnected from the world of pull requests and IPOs.** We were wrong.
Sid didn't just go into treatment; he went into **root cause analysis**. He discovered what every cancer patient eventually learns: the medical industry is the ultimate "black box" silo.
**Data doesn't move.
Protocols are proprietary.
Innovation happens at the speed of a 1998 dial-up modem.** For someone who built a career on open-source collaboration, this wasn't just a personal threat; it was a structural insult.
In early 2025, while undergoing grueling treatments, he didn't just "rest." **He founded a new venture aimed at accelerating the very research that was keeping him alive.** He realized that the bottleneck in oncology wasn't a lack of brilliant minds—it was a lack of a unified "version control" for cancer data.
We love the "war on cancer" rhetoric because it makes us feel like we’re doing something. But wars are about destruction.
**Founding a company is about construction.** When you’re "fighting" a disease, you’re in a defensive crouch. When you’re building a solution, you’re in an offensive sprint.
**The mainstream take is that "stress kills" and "work is the enemy of healing."** I’m here to argue the opposite. For a founder, the loss of agency is more toxic than the chemotherapy.
**By treating his diagnosis as a series of engineering hurdles, Sid reclaimed the one thing cancer tries to steal: his identity.**
He isn't just a "patient" anymore. He’s a **stakeholder with a deadline.** That shift in perspective changes the chemistry of the brain.
Instead of waiting for a doctor to tell him his "odds," he’s using models like **Claude 4.6 to cross-reference rare osteosarcoma mutations** against thousands of existing drug patents that the pharmaceutical giants have left to gather dust.
Through Sid’s journey over the last two years, we can see a new mental model emerging for how to handle "unsolvable" personal crises.
I call it **The Founder’s Immune Response.** It consists of three distinct layers that any of us can apply when the "system" fails us.
In the medical world, your records are often held hostage by different providers.
**Sid applied the GitLab "public by default" philosophy to his own charts.** He didn't just keep his doctors in the loop; he looked for ways to make oncological data as accessible as a GitHub repo.
**When you make the problem public, you invite the world to help you debug it.** Most people hide their struggles because of "stigma." But stigma is just another word for a lack of documentation.
By being open about his osteosarcoma, Sid created a "signal" that attracted other researchers, founders, and survivors who had the missing pieces of his puzzle.
Traditional medicine moves through clinical trials that take 5 to 10 years. **If you have an aggressive bone cancer, you don't have a 10-year roadmap.** You have a 10-week roadmap.
Sid’s new ventures aren't looking for the "perfect" cure; they are looking for the **Minimum Viable Treatment (MVT).**
He is pushing for "N-of-1" trials—personalized medicine where the "iteration" happens in real-time based on how a specific patient’s tumor reacts to a specific compound.
**It’s the biological equivalent of a CI/CD pipeline.** You don't wait for a major release; you push small updates to the "production" (the patient) every single day.
In tech, we love the "moonshot." In medicine, we love the "miracle drug." But most problems are solved by **optimizing the boring stuff.** Sid realized that the "unsolved" parts of cancer are often just logistical failures—getting the right blood sample to the right sequencer in the right timezone.
**His recent investments focus on the "infrastructure" of oncology.** By building the "pipes" that allow data to flow between research institutions, he’s doing for cancer what he did for software development: removing the friction that stops smart people from actually shipping results.
Everyone is currently obsessed with the "AI revolution" in medicine.
**But ChatGPT 5 and Gemini 2.5 are only as good as the data they are trained on.** Currently, the best cancer data is locked behind the paywalls of academic journals and the legal departments of Big Pharma.
**Sid is betting that transparency will do to oncology what it did to the Linux kernel.** If you make the data open, the "bugs" (the tumors) have nowhere to hide.
He’s funding companies that don't just "do research," but **build platforms for others to do research better.**
This is a direct challenge to the "Proprietary Medicine" model.
**The old guard believes that secrets equal value.** Sid is proving that in a race against time, secrets are just technical debt that leads to death.
He’s essentially trying to **fork the cancer research industry** and build a version that actually works for the end-user.
You might be reading this thinking, "That’s great for a billionaire, but what about me?" **The lesson isn't that you need $100 million to survive.** The lesson is that your "work" and your "life" aren't two separate buckets.
**We’ve been lied to about "work-life balance."** We’ve been told that when life gets hard, work should stop. But for many of us, our work is where our sense of agency lives.
When your health, or your relationship, or the economy goes sideways, **the most "restful" thing you can do is find a problem you can actually solve.**
If a man with a "terminal" diagnosis can find the energy to launch two companies and a foundation, **what is your excuse for not fixing that "broken" process in your own department?** We often wait for "permission" to innovate, or we wait for the "right time." Sid’s story proves that the "right time" is usually when everything is falling apart.
By mid-2027, I predict we will see a massive shift in how we view "patients." We are moving away from the era of the **Passive Recipient** (someone who just does what the doctor says) and into the era of the **Active Architect.**
**Sid Sijbrandij isn't just fighting cancer; he’s refactoring it.** He’s taking the same principles that allowed a distributed team of thousands to build GitLab and applying them to the most complex biological puzzle in history.
Whether he "wins" in the traditional sense is almost beside the point—**he has already changed the "source code" for how we face the end.**
He has replaced the "Why me?" with "How do we fix this?" And in doing so, he’s given a roadmap to every person facing a crisis that feels bigger than they are.
**You don't have to be a victim of your circumstances if you choose to be the founder of your response.**
---
**Have you ever found that a "distraction" like work actually helped you through a personal crisis, or do you think the "rest and recover" model is still the only way?
Let’s talk about it in the comments.**
---
Hey friends, thanks heaps for reading this one! 🙏
If it resonated, sparked an idea, or just made you nod along — I'd be genuinely stoked if you'd show some love. A clap on Medium or a like on Substack helps these pieces reach more people (and keeps this little writing habit going).
→ Pythonpom on Medium ← follow, clap, or just browse more!
→ Pominaus on Substack ← like, restack, or subscribe!
Zero pressure, but if you're in a generous mood and fancy buying me a virtual coffee to fuel the next late-night draft ☕, you can do that here: Buy Me a Coffee — your support (big or tiny) means the world.
Appreciate you taking the time. Let's keep chatting about tech, life hacks, and whatever comes next! ❤️